NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Enters Manufacturing and Supply Agreement in California

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned California subsidiary, Pivot Naturals, LLC, has signed a definitive manufacturing and supply agreement with Stoney LLC, a leading brand of cannabis products in the state of California. Per the terms of the agreement, Stoney has agreed to purchase Pivot’s suite of Ready-To-Infuse-Cannabis (“RTIC”) powderized products, including formulated capsules for targeted effects, bulk powder for baking additives, single serve stick packs and pet food supplements. Order quantities will be determined in rolling 30-day periods commencing in 2018. “I am thrilled to execute our first Manufacturing and Supply Agreement in California,” Patrick J. Rolfes, president of Pivot Naturals, stated in the news release. “This positions our patented RTIC powderization technology as an industry changing solution. This is a critical milestone that further validates Pivot as a leading supplier of premium, science-based cannabis products.”

To view the full press release, visit http://nnw.fm/2UnB8

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green StreamHealth Solutions Inc. (“PGS”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. PGS has acquired worldwide rights to “RTIC” Ready-To-Infuse Cannabis powder to oil technology, BiPhasix Transdermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral) and Thrudermic Transdermal Nanotechnology (transdermal) for the delivery and commercialization of cannabinoid, cannabidiol, and tetrahydrocannabinol-based products. PGS’ initial product development candidates will include topical treatments for women’s sexual dysfunction (PGS-N005), as well as psoriasis (PGS-N007), and an oral product (PGS-N001) for cancer supportive care. For more information, visit the company’s website at www.PivotPharma.com

More from NetworkNewsBreaks

NetworkNewsBreaks – EVIO, Inc. (EVIO) Posts Fiscal Q2 2018 Financial Results NetworkNewsBreaks – Marijuana Company of America, Inc. (MCOA) JV Completes Setup of 10,000 sq. ft. Greenhouse Space NetworkNewsBreaks – FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) Announces Digital User Acquisition Initiatives

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

Feds: Uber self-driving SUV saw pedestrian, did not brake

May 25, 2018

DETROIT — The autonomous Uber SUV that struck and killed an Arizona pedestrian in March spotted the woman about six seconds before hitting her, but did not stop because the system used to automatically apply brakes in potentially dangerous situations had been disabled, according to federal investigators. In a preliminary report on the crash, the National Transportation Safety Board said Thursday that emergency braking is not enabled while Uber's cars are under computer control, "to reduce the potential for erratic vehicle behavior." Instead, Uber relies on a human backup driver to intervene. The system, however, is not designed to alert...

Brewery told to stop making beer with hemp-derived extract

May 25, 2018

SAN FRANCISCO — U.S. officials have ordered a San Francisco brewery to stop producing a specialty beer containing cannabidiol, the hemp-derived extract known as CBD, because it lacks the proper permitting. The U.S. Alcohol and Tobacco Tax and Trade Bureau is allowing Black Hammer Brewing to sell the rest of the CBD beer it has already brewed, including an IPA called Toke Back Mountain that was introduced in 2017 in honor of the 4/20 marijuana holiday. Like marijuana, hemp is a cannabis plant. But it contains very little THC, the compound that gives pot its high. CBD is seen by...

Q&A: Would Trump's proposed tariffs on imported autos work?

May 25, 2018

WASHINGTON — Do Subaru Foresters, BMW 3-series sedans and Toyota Priuses pose a threat to U.S. national security? President Donald Trump suspects they might. He's ordered the Commerce Department to investigate whether the peril is dire enough to justify tariffs or quotas on imports of foreign-made vehicles and auto parts to the United States. The announcement sent shares of Japanese and European automakers tumbling in global stock markets Thursday. It also aggravated trade tensions between the Unites States and allies like Germany and Japan. And most economists and trade analysts ridiculed any notion that national security might be imperiled by...

Gap 1Q profit misses Street estimates

May 25, 2018

SAN FRANCISCO — Gap Inc. says its first-quarter profit missed forecasts, but revenue beat estimates. The San Francisco-based clothing chain earned $164 million, or 42 cents per share, on revenue of $3.78 billion Analysts expected a quarterly profit of 45 cents and revenue of $3.61 billion, according to Zacks Investment Research. Sales in existing stores, a key retail metric, rose 1 percent during the quarter. Looking ahead, Gap says it still expects full-year earnings to be $2.55 to $2.70 per share. Gap shares slid 7 percent in extended after-hours trading.

The Latest: Auto workers head cautious about tariff proposal

May 25, 2018

WASHINGTON — The Latest on the Trump administration's interest in putting tariffs on auto imports (all times local): 3:50 p.m. United Auto Workers President Dennis Williams cautiously backed the U.S. decision to explore raising tariffs on imported vehicles. He says Thursday that the nation should have looked at them long ago because it has become a dumping ground for foreign companies that sometimes are subsidized by governments. "I welcome the fact that they're investigating this and they're even considering the tariffs, if they need to be done. But I'm often cautious about tariffs, because we do do some exporting as...

Emporium Post fulfils the need to know all things about consumers and how businesses can take this opportunity to reach their own customers.

Contact us: sales@emporiumpost.com

Join our mailing list now!